Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metastasis suppressor genes: basic biology and potential clinical use.

Patricia S Steeg1, Taoufik Ouatas, Douglas Halverson

  • 1Women's Cancers Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA. steegp@mail.nih.gov

Clinical Breast Cancer
|May 15, 2003
PubMed
Summary

Understanding breast cancer metastasis is key to new therapies. Suppressing metastasis-suppressor genes can halt tumor spread and benefit patients, offering a promising therapeutic avenue.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trastuzumab deruxtecan efficacy, FcRn-facilitated penetration of the blood-tumor barrier, and distribution to tumor cells in HER2+ brain metastasis model systems.

Neuro-oncology·2026
Same author

Proteogenomic characterization of invasive breast tumors in young women.

NPJ breast cancer·2025
Same author

Navigating the oncology drug discovery and development process with programmes supported by the National Institutes of Health.

The Lancet. Oncology·2024
Same author

Distinct uptake and elimination profiles for trastuzumab, human IgG, and biocytin-TMR in experimental HER2+ brain metastases of breast cancer.

Neuro-oncology·2024
Same author

The activity of a PI3K δ-sparing inhibitor, MEN1611, in non-small cell lung cancer cells with constitutive activation of the PI3K/AKT/mTOR pathway.

Frontiers in oncology·2023
Same author

The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study.

Clinical & experimental metastasis·2023

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Metastatic breast cancer significantly impacts patient morbidity and mortality.
  • Understanding the molecular mechanisms of metastasis is crucial for developing novel therapeutic strategies.
  • While oncogenes promote metastasis, some genes act as metastasis suppressors, showing reduced expression in aggressive tumors.

Purpose of the Study:

  • To investigate the role of metastasis-suppressor genes in controlling breast cancer spread.
  • To explore the potential of re-expressing metastasis suppressors as a therapeutic strategy.
  • To hypothesize the clinical benefit of elevating metastasis suppressor gene expression in high-risk breast cancer patients.

Main Methods:

  • Analyzing gene expression levels in metastatic versus non-metastatic tumor cells.

Related Experiment Videos

  • Evaluating the effect of re-expressing metastasis-suppressor genes in vitro and in vivo.
  • Investigating signaling pathways influenced by metastasis suppressor gene products.

    • Main Results:

    • Re-expression of metastasis-suppressor genes significantly reduces metastatic behavior without affecting tumorigenicity.
    • Metastasis suppressors primarily act during the outgrowth of micrometastatic cells at distant sites.
    • Known metastasis suppressors possess diverse biochemical functions impacting signaling pathways.

    Conclusions:

    • Elevating metastasis suppressor gene expression holds potential for halting metastatic colonization in breast cancer.
    • Targeting metastasis suppressor genes may offer clinical benefit to adjuvant high-risk breast cancer patients.
    • Further research into agents that increase metastasis suppressor gene expression is warranted, requiring tailored clinical trial designs.